These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38239867)

  • 21. Predictive Roles of ADAM17 in Patient Survival and Immune Cell Infiltration in Hepatocellular Carcinoma.
    Ding T; Yu Y; Gao L; Xiang L; Xu B; Gu B; Chen H
    Int J Mol Sci; 2023 Dec; 24(23):. PubMed ID: 38069391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LPCAT1 acts as an independent prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma.
    Li L; Wang X; Ding Y; Hui N; Su B; Yang M
    Eur J Med Res; 2022 Oct; 27(1):216. PubMed ID: 36307879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive Pan-Cancer Genomic Analysis Reveals PHF19 as a Carcinogenic Indicator Related to Immune Infiltration and Prognosis of Hepatocellular Carcinoma.
    Zhu ZY; Tang N; Wang MF; Zhou JC; Wang JL; Ren HZ; Shi XL
    Front Immunol; 2021; 12():781087. PubMed ID: 35069553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coiled-Coil Domain-Containing Protein 45 Is a Potential Prognostic Biomarker and Is Associated with Immune Cell Enrichment of Hepatocellular Carcinoma.
    Liu S; Jia L; Quan B; Rong G; Li M; Xie R; Cai Y; Bi Y; Han S
    Dis Markers; 2022; 2022():7745315. PubMed ID: 36618966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TMEM147 Correlates with Immune Infiltration and Serve as a Potential Prognostic Biomarker in Hepatocellular Carcinoma.
    Cheng S; Li J; Xu M; Bao Q; Wu J; Sun P; Han B
    Anal Cell Pathol (Amst); 2023; 2023():4413049. PubMed ID: 37305689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aberrantly Expressed MicroRNAs in Cancer-Associated Fibroblasts and Their Target Oncogenic Signatures in Hepatocellular Carcinoma.
    Eun JW; Ahn HR; Baek GO; Yoon MG; Son JA; Weon JH; Yoon JH; Kim HS; Han JE; Kim SS; Cheong JY; Kim BW; Cho HJ
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. UHRF1 Could Be a Prognostic Biomarker and Correlated with Immune Cell Infiltration in Hepatocellular Carcinoma.
    Li D; Chen B; Zeng Y; Wang H
    Int J Gen Med; 2021; 14():6769-6776. PubMed ID: 34675635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PPM1D is a potential prognostic biomarker and correlates with immune cell infiltration in hepatocellular carcinoma.
    Yu Z; Song Y; Cai M; Jiang B; Zhang Z; Wang L; Jiang Y; Zou L; Liu X; Yu N; Mao X; Peng C; Liu S
    Aging (Albany NY); 2021 Sep; 13(17):21294-21308. PubMed ID: 34470916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High expression of nectin-1 indicates a poor prognosis and promotes metastasis in hepatocellular carcinoma.
    Wang X; Xing Z; Chen H; Yang H; Wang Q; Xing T
    Front Oncol; 2022; 12():953529. PubMed ID: 36059705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EIF2S2 is a novel independent prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma.
    Liu J; Liu T; Zhang C; He J; Zhou D; Wang Z; Wang R
    Front Genet; 2022; 13():992343. PubMed ID: 36276981
    [No Abstract]   [Full Text] [Related]  

  • 31. Over-expression of RRM2 predicts adverse prognosis correlated with immune infiltrates: A potential biomarker for hepatocellular carcinoma.
    Qin Z; Xie B; Qian J; Ma X; Zhang L; Wei J; Wang Z; Fan L; Zhu Z; Qian Z; Yin H; Zhu F; Tan Y
    Front Oncol; 2023; 13():1144269. PubMed ID: 37056349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exogenous interleukin-33 promotes hepatocellular carcinoma growth by remodelling the tumour microenvironment.
    Wang W; Wu J; Ji M; Wu C
    J Transl Med; 2020 Dec; 18(1):477. PubMed ID: 33308251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TANK-Binding Kinase 1 (TBK1) Serves as a Potential Target for Hepatocellular Carcinoma by Enhancing Tumor Immune Infiltration.
    Jiang Y; Chen S; Li Q; Liang J; Lin W; Li J; Liu Z; Wen M; Cao M; Hong J
    Front Immunol; 2021; 12():612139. PubMed ID: 33679751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Construction of Novel lncRNA-miRNA-mRNA Network Associated With Recurrence and Identification of Immune-Related Potential Regulatory Axis in Hepatocellular Carcinoma.
    Zhan T; Gao X; Wang G; Li F; Shen J; Lu C; Xu L; Li Y; Zhang J
    Front Oncol; 2021; 11():626663. PubMed ID: 34336642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive Analysis of HHLA2 as a Prognostic Biomarker and Its Association With Immune Infiltrates in Hepatocellular Carcinoma.
    Ding L; Yu Q; Yang S; Yang WJ; Liu T; Xian JR; Tian TT; Li T; Chen W; Wang BL; Pan BS; Zhou J; Fan J; Yang XR; Guo W
    Front Immunol; 2022; 13():831101. PubMed ID: 35371079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Construction of circRNA-Based ceRNA Network to Reveal the Role of circRNAs in the Progression and Prognosis of Hepatocellular Carcinoma.
    Deng R; Cui X; Dong Y; Tang Y; Tao X; Wang S; Wang J; Chen L
    Front Genet; 2021; 12():626764. PubMed ID: 33719338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of G6PC as a potential prognostic biomarker in hepatocellular carcinoma based on bioinformatics analysis.
    Tian L; Liao Y
    Medicine (Baltimore); 2022 Aug; 101(33):e29548. PubMed ID: 35984176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and validation of Birc5 as a novel activated cell cycle program biomarker associated with infiltration of immunosuppressive myeloid-derived suppressor cells in hepatocellular carcinoma.
    Liu Y; Chen X; Luo W; Zhao Y; Nashan B; Huang L; Yuan X
    Cancer Med; 2023 Aug; 12(15):16370-16385. PubMed ID: 37326143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ASRGL1 Correlates With Immune Cell Infiltration in Hepatocellular Carcinoma and Can Serve as a Prognostic Biomarker.
    Xue C; Gao P; Cui X; Zhang X; Lei J; Li R; Zhu C; Qin X
    Front Oncol; 2021; 11():680070. PubMed ID: 34249720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. VCAN, expressed highly in hepatitis B virus-induced hepatocellular carcinoma, is a potential biomarker for immune checkpoint inhibitors.
    Wang MQ; Li YP; Xu M; Tian Y; Wu Y; Zhang X; Shi JJ; Dang SS; Jia XL
    World J Gastrointest Oncol; 2022 Oct; 14(10):1933-1948. PubMed ID: 36310697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.